Diego F. Calvisi

21.6k total citations · 3 hit papers
215 papers, 11.5k citations indexed

About

Diego F. Calvisi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Diego F. Calvisi has authored 215 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Molecular Biology, 59 papers in Oncology and 56 papers in Cancer Research. Recurrent topics in Diego F. Calvisi's work include Cancer, Hypoxia, and Metabolism (30 papers), Cancer-related Molecular Pathways (29 papers) and Cancer Mechanisms and Therapy (29 papers). Diego F. Calvisi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (30 papers), Cancer-related Molecular Pathways (29 papers) and Cancer Mechanisms and Therapy (29 papers). Diego F. Calvisi collaborates with scholars based in Germany, United States and Italy. Diego F. Calvisi's co-authors include Xin Chen, Snorri S. Thorgeirsson, Sara Ladu, Ju‐Seog Lee, Matthias Evert, Valentina M. Factor, Frank Dombrowski, Rosa M. Pascale, Francesco Feo and In‐Sun Chu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Diego F. Calvisi

211 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

2006 722 citations Diego F. Calvisi et al. profile →
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

2004 689 citations Diego F. Calvisi et al. Hepatology profile →
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC

2006 558 citations Diego F. Calvisi, Sara Ladu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego F. Calvisi Germany	55	7.0k	3.4k	2.4k	2.2k	1.7k	215	11.5k
Ju‐Seog Lee United States	61	7.9k 1.1×	3.9k 1.2×	3.7k 1.5×	1.9k 0.9×	1.4k 0.8×	218	13.3k
Terence K. Lee Hong Kong	59	6.3k 0.9×	3.5k 1.0×	4.3k 1.8×	1.9k 0.8×	876 0.5×	170	10.8k
Valentina M. Factor United States	55	5.1k 0.7×	2.2k 0.7×	2.1k 0.9×	2.7k 1.2×	1.2k 0.7×	109	8.7k
Satdarshan P. Monga United States	58	6.9k 1.0×	1.4k 0.4×	1.6k 0.7×	4.2k 1.9×	2.1k 1.2×	229	11.7k
Hui‐Chuan Sun China	58	5.0k 0.7×	4.2k 1.2×	3.1k 1.3×	3.7k 1.7×	2.0k 1.1×	308	11.8k
Shoji Nakamori Japan	55	3.6k 0.5×	2.0k 0.6×	4.4k 1.9×	1.6k 0.7×	1.5k 0.9×	276	10.1k
Stephanie Ma Hong Kong	47	5.0k 0.7×	3.0k 0.9×	3.9k 1.6×	1.4k 0.6×	598 0.3×	125	8.8k
Koji Umeshita Japan	51	2.6k 0.4×	1.8k 0.5×	2.2k 0.9×	3.4k 1.5×	1.6k 0.9×	290	8.5k
Nathan W. Werneburg United States	42	2.9k 0.4×	1.2k 0.3×	1.2k 0.5×	930 0.4×	2.6k 1.5×	56	6.3k
Wolfgang Mikulits Austria	44	4.1k 0.6×	1.6k 0.5×	2.4k 1.0×	955 0.4×	531 0.3×	116	6.9k

Countries citing papers authored by Diego F. Calvisi

Since Specialization

Citations

This map shows the geographic impact of Diego F. Calvisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego F. Calvisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego F. Calvisi more than expected).

Fields of papers citing papers by Diego F. Calvisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego F. Calvisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego F. Calvisi. The network helps show where Diego F. Calvisi may publish in the future.

Co-authorship network of co-authors of Diego F. Calvisi

This figure shows the co-authorship network connecting the top 25 collaborators of Diego F. Calvisi. A scholar is included among the top collaborators of Diego F. Calvisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego F. Calvisi. Diego F. Calvisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Wei‐Ting, Yi Zhang, Jingxiao Wang, et al.. (2025). β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans. Hepatology. 83(2). 215–230. 1 indexed citations

Zushin, Peter‐James H., Hyo Min Park, Sharon M. Louie, et al.. (2024). FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma. Molecular Cancer Research. 22(6). 585–595. 3 indexed citations

Deng, Shanshan, Xinjun Lu, Xue Wang, et al.. (2024). Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma. Cell Death and Disease. 15(6). 441–441. 1 indexed citations

Scheiter, Alexander, Felix Keil, Cédric Coulouarn, et al.. (2022). Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. Journal of Personalized Medicine. 12(8). 1270–1270. 3 indexed citations

Mancarella, Serena, Grazia Serino, Isabella Gigante, et al.. (2022). CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. Journal of Experimental & Clinical Cancer Research. 41(1). 16 indexed citations

Pellegrino, Rossella, Abhishek Thavamani, Diego F. Calvisi, et al.. (2021). Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCC. Cancers. 13(2). 199–199. 8 indexed citations

Scheiter, Alexander, Florian Lüke, Felix Keil, et al.. (2021). STRN-ALKFusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. JCO Precision Oncology. 5(5). 1507–1513. 4 indexed citations

Evert, Katja, Thomas Dienemann, Christoph Brochhausen, et al.. (2021). Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(1). 97–108. 34 indexed citations

Chen, Xinyan, Xinyan Chen, András Kiss, et al.. (2020). CDK9 is dispensable for YAP‐driven hepatoblastoma development. Pediatric Blood & Cancer. 67(5). e28221–e28221. 3 indexed citations

10.

Xu, Meng, Haichuan Wang, Jingxiao Wang, et al.. (2020). mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy. American Journal Of Pathology. 190(4). 817–829. 14 indexed citations

11.

Chen, Bin, Lana X. Garmire, Diego F. Calvisi, et al.. (2020). Publisher Correction: Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 2 indexed citations

12.

Wang, Jingxiao, Haichuan Wang, Ning Ding, et al.. (2019). Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis. Journal of Hepatology. 71(4). 742–752. 47 indexed citations

13.

Méndez‐Lucas, Andrés, Xiaolei Li, Junjie Hu, et al.. (2017). Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities. Cancer Research. 77(16). 4355–4364. 67 indexed citations

14.

Brooks, Jennifer D., Bettina Fleischmann-Mundt, Norman Woller, et al.. (2017). Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer. Cancer Research. 78(2). 475–488. 55 indexed citations

15.

Calvisi, Diego F., Hyuk Moon, Silvia Ribback, et al.. (2015). Transgenic mouse model expressing P53R172H, luciferase, EGFP and KRASG12D in a single open reading frame for live imaging of tumor. Scientific Reports. 5(1). 8053–8053. 10 indexed citations

16.

Song, Su Jung, Min Sup Song, Soonjoung Kim, et al.. (2009). Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity. Cancer Research. 69(6). 2314–2323. 40 indexed citations

17.

Calvisi, Diego F., Howard Donninger, Michele D. Vos, et al.. (2009). NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53. Cancer Research. 69(11). 4629–4637. 50 indexed citations

18.

Calvisi, Diego F., Federico Pinna, Sara Ladu, et al.. (2008). Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase–Mediated Control of Growth in Human Hepatocellular Carcinoma. Cancer Research. 68(11). 4192–4200. 107 indexed citations

19.

Miglio, Maria R. De, Patrizia Virdis, Diego F. Calvisi, et al.. (2006). Mapping a Sex Hormone–Sensitive Gene Determining Female Resistance to Liver Carcinogenesis in a Congenic F344.BN- Hcs4 Rat. Cancer Research. 66(21). 10384–10390. 6 indexed citations

20.

Novoselov, Sergey V., Diego F. Calvisi, Vyacheslav M. Labunskyy, et al.. (2005). Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene. 24(54). 8003–8011. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact